07/12/2023
🔬Exciting day for those interested in learning more about the future of personalized regenerative medicine! Join our client, Cellino, for the start of the Advanced Research Projects Agency for Health Deep Dive Series 3, featuring their winning scalable solution "Your Cells, Your Cure" idea!
Cellino’s leadership, including their Co-Founder and Chief Product Officer, Marinna Madrid, PhD, and Chief of Staff, Willie T. Reaves Jr., had the privilege of being among the invited thought leaders in a White House Listening Session on “Harnessing Biotechnology and Biomanufacturing for Health Breakthroughs,” hosted by the Biden Administration.
It's incredible to see the strong alignment between their goals and the “Bold Goals for U.S. Biotechnology and Biomanufacturing” plan, particularly regarding the scale-up of cell-based therapies. Goal 3.2 aims to “Enable Scale-Up: In 20 years, increase the manufacturing scale of cell-based therapies to expand access, decrease health inequities, and reduce the manufacturing cost of cell-based therapies by 10-fold.”
Swipe to learn more about the upcoming live session and hear from Cellino’s Co-Founder and Chief Product Officer, Marinna Madrid, PhD, and Chief of Staff, Willie T. Reaves Jr., as they share Cellino’s multidisciplinary approach for scaling autologous cell therapies.
📸: Cellino’s Chief of Staff, Willie & Co-Founder, Marinna
🧬: Graphic by Polyplexus.com